摘要 : This paper explores policy mechanisms behind New Zealand's remarkable track record of cost containment in public pharmaceutical spending, contrasting with most other advanced economies. We drew on a review of official policy docum... 展开
作者 | Main~ Ben Csanadi~ Marcell Ozieranski~ Piotr |
---|---|
作者单位 | |
期刊名称 | 《Health economics, policy and law.》 |
总页数 | 18 |
语种/中图分类号 | 英语 / R1 |
关键词 | Health technology assessment management reimbursement pharmaceutical spending pharmaceutical pricing strategies New Zealand MANAGED ENTRY AGREEMENTS DRUG REIMBURSEMENT UNITED-STATES MECHANISMS |
馆藏号 | N2008EPST0005883 |